Skip to main content

Table 4 Relative risks for COVID-19 deaths, by risk groups and country

From: Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis

Country

Source

Sample size

Date

Risk group

Outcome

Relative risk (95%CI)

Spain

ISCIII

250287

21.05.2020

Cardiovascular disease

Death

4.6 (4.6–4.7)

Respiratory disease

3.0 (3.0–3.0)

Diabetes

3.4 (3.4–3.5)

At least one comorbidity

6.6 (6.5–6.6)

France

Santé publique France

3784

18.05.2020

Morbid obesity (BMI>40)

Death

0.9 (0.6–1.2)

Diabetes

1.3 (1.2–1.5)

Cardiac disease

1.9 (1.7–2.0)

Pulmonary disease

1.5 (1.3–1.7)

Immunodeficiency

1.6 (1.3–1.8)

Renal disease

1.6 (1.4–1.9)

Neuromuscular disorder

2.1 (1.8–2.4)